Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on August 13, 2026

Aug. 13, 2026

Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 13, 2026

XBP Global Holdings, Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026

Indeterminate GlobeNewswire

Aug. 13, 2026

Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements

Indeterminate GlobeNewswire

Aug. 13, 2026

Mobilicom Reports Financial and Operational Results for the Six Months Ended June 30, 2026

Indeterminate GlobeNewswire

Aug. 13, 2026

Applied Materials Announces Third Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Micron Ventures Launches $250 Million Fund to Invest in the Next Generation of AI

Indeterminate GlobeNewswire

Aug. 13, 2026

ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

Indeterminate GlobeNewswire

Aug. 13, 2026

Mdxhealth Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights

Indeterminate GlobeNewswire

Aug. 13, 2026

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Noldor Appoints Tom Anderson as Head of Sales

Indeterminate GlobeNewswire

Aug. 13, 2026

How to Earn Interest on Business Cash: Balance Cash Explains How Companies Put Idle Operating Cash to Work Without Switching Banks

Indeterminate GlobeNewswire

Aug. 13, 2026

Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success

Indeterminate GlobeNewswire

Aug. 13, 2026

TSI Incorporated Has Earned License to the Works with WELL Trademark for AirAssure™ Indoor Air Quality Monitors

Indeterminate GlobeNewswire

Aug. 13, 2026

The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

Indeterminate GlobeNewswire

Aug. 13, 2026

DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia

Indeterminate GlobeNewswire